RxDoctor Payments DataLook up a doctor →

Thomas Kintanar, MD

Family Medicine · Fort Wayne, INNPI 1750326351

Payments from drug & device makers

$184,990in general payments, 2019–2025

Across 1,556 payments — averaging $118.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$44K
  • Astellas Pharma US Inc$42K
  • Otsuka America Pharmaceutical, Inc.$35K
  • Bayer$26K
  • Sanofi-aventis U.S. LLC$18K
  • Novo Nordisk$3K
  • plus $17K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Phathom Pharmaceuticals, Inc.60$44,146
Astellas Pharma US Inc69$42,040
Otsuka America Pharmaceutical, Inc.47$34,598
Bayer51$25,651
Sanofi-aventis U.S. LLC58$17,948
Novo Nordisk100$3,398
AbbVie(2 entities)274$3,058
AstraZeneca91$2,303
Pfizer137$1,846
Lilly USA, LLC108$1,386
GSK79$774
Boehringer Ingelheim50$692
Merck59$599
Amgen(2 entities)29$586
Johnson & Johnson35$558
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC36$516
Amarin Pharma, Inc.28$374
Takeda Pharmaceuticals U.S.A., Inc.20$330
Teva Pharmaceuticals USA, Inc.17$314
Sumitomo Pharma America, Inc.19$277
Axsome Therapeutics, Inc.8$233
Sunovion Pharmaceuticals Inc.18$225
Adlon Therapeutics L.p.12$218
Vanda Pharmaceuticals Inc.9$216
Abbott9$212
Kowa Pharmaceuticals America, Inc.12$206
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$189
Otsuka Pharmaceutical Development & Commercialization, Inc.4$179
Corium, LLC10$160
Nestle Healthcare Nutrition Inc.10$156
Xeris Pharmaceuticals, Inc.9$136
Acadia Pharmaceuticals Inc4$132
Novartis8$111
Supernus Pharmaceuticals, Inc.5$86
Exact Sciences5$83
Lundbeck LLC4$78
Amneal Pharmaceuticals LLC5$77
UCB, Inc.1$75
Avanir Pharmaceuticals, Inc.4$73
Arbor Pharmaceuticals, Inc.5$69
Esperion Therapeutics, Inc.4$64
Corcept Therapeutics3$62
Paratek Pharmaceuticals, Inc.3$56
Antares Pharma, Inc.3$52
Medtronic1$46
Sun Pharmaceutical Industries Inc.1$45
E.r. Squibb & Sons, L.L.C.3$44
Ardelyx, Inc.2$41
Idorsia Pharmaceuticals US Inc2$32
Lexicon Pharmaceuticals, Inc.2$32
Philips North America LLC2$30
Zyla Life Sciences, Inc.2$28
Boston Scientific1$27
Ironwood Pharmaceuticals, Inc2$27
Shire North American Group Inc2$26
Olympus America Inc.1$24
Neurelis, Inc.1$19
Assertio Therapeutics, Inc.1$17
Ironshore Pharmaceuticals Inc.1$12

How this compares

$184,990 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana →

Medicare billing

Part B allowed, 2024
$134,805
Medicare patients
414
Services billed
7,754

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Fort Wayne

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →